• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Shilpa Medicare Limited — Updates, 22-09-2025: General Updates

    22-09-2025 | 11:05 pm

    Shilpa Medicare secured initial authorization from EMA for Rivaroxaban Orodispersible Films (ODF). This generic version of Xarelto, unique in ODF form, targets Europe's USD 2.5 billion market.

    No comments yet. Be the first to comment!

    All announcements from Shilpa Medicare Limited